Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Acta Neuropathologica
|
July 27, 2022
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer's disease
Antonio Boza-Serrano, Agathe Vrillon, Karolina Minta, et al.
Alzheimer'S Research & Therapy
|
March 10, 2023
Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts
Juan Lantero-Rodriguez, Agathe Vrillon, Aida Fernández-Lebrero, et al.
Acta Neuropathologica
|
January 6, 2024
CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease
Juan Lantero-Rodriguez, Laia Montoliu-Gaya, Andrea L Benedet, et al.
Acta Neuropathologica
|
April 21, 2025
Correction: CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease
Juan Lantero-Rodriguez, Laia Montoliu-Gaya, Andrea L Benedet, et al.
BMJ Open
|
June 2, 2019
What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France
Emmanuel Cognat, François Mouton Liger, Anne-Cécile Troussière, et al.
Neurology
|
August 15, 2022
A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging
Julien Dumurgier, Séverine Sabia, Henrik Zetterberg, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 12, 2025
Usefulness of Cerebrospinal Fluid Alzheimer's disease biomarkers in older patients: Evidence from a national multicenter prospective study
Théodore Decaix, François Mouton-Liger, Julien Dumurgier, et al.
JAMA Neurology
|
October 18, 2021
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
Andréa L Benedet, Marta Milà-Alomà, Agathe Vrillon, et al.
Plos Medicine
|
August 21, 2020
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study
Hana Saddiki, Aurore Fayosse, Emmanuel Cognat, et al.
Nature Aging
|
November 12, 2024
Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability
Joseph Therriault, Shorena Janelidze, Andréa Lessa Benedet, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Acta Neuropathologica
|
July 27, 2022
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer's disease
Antonio Boza-Serrano, Agathe Vrillon, Karolina Minta, et al.
Alzheimer'S Research & Therapy
|
March 10, 2023
Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts
Juan Lantero-Rodriguez, Agathe Vrillon, Aida Fernández-Lebrero, et al.
Acta Neuropathologica
|
January 6, 2024
CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease
Juan Lantero-Rodriguez, Laia Montoliu-Gaya, Andrea L Benedet, et al.
Acta Neuropathologica
|
April 21, 2025
Correction: CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease
Juan Lantero-Rodriguez, Laia Montoliu-Gaya, Andrea L Benedet, et al.
BMJ Open
|
June 2, 2019
What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France
Emmanuel Cognat, François Mouton Liger, Anne-Cécile Troussière, et al.
Neurology
|
August 15, 2022
A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging
Julien Dumurgier, Séverine Sabia, Henrik Zetterberg, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 12, 2025
Usefulness of Cerebrospinal Fluid Alzheimer's disease biomarkers in older patients: Evidence from a national multicenter prospective study
Théodore Decaix, François Mouton-Liger, Julien Dumurgier, et al.
JAMA Neurology
|
October 18, 2021
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
Andréa L Benedet, Marta Milà-Alomà, Agathe Vrillon, et al.
Plos Medicine
|
August 21, 2020
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study
Hana Saddiki, Aurore Fayosse, Emmanuel Cognat, et al.
Nature Aging
|
November 12, 2024
Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability
Joseph Therriault, Shorena Janelidze, Andréa Lessa Benedet, et al.
Page
of 9